Elies Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 05-12-2024
- Revenue 36.94%
(FY 2022)
- Profit 33.17%
(FY 2022)
- Ebitda 138.15%
(FY 2022)
- Net Worth 34.00%
(FY 2022)
- Total Assets 153.78%
(FY 2022)
About Elies Biotech
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Kumaravel Indumathy and Aravindh serve as directors at the Company.
- CIN/LLPIN
U74999TZ2019PTC032954
- Company No.
032954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Erode, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Elies Biotech Private Limited offer?
Elies Biotech Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Fresh, Dried & Preserved Vegetables, Mushroom, Fertilizers and Soil Additives, Bio Fertilizers, Waste Decomposer.
Who are the key members and board of directors at Elies Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumaravel Indumathy  | Director | 06-Nov-2019 | Current |
| Aravindh | Director | 06-Nov-2019 | Current |
Financial Performance of Elies Biotech.
Elies Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.94% increase. The company also saw a substantial improvement in profitability, with a 33.17% increase in profit. The company's net worth Soared by an impressive increase of 34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elies Biotech?
Unlock access to Elies Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 02 Jul 2021 | ₹0.50 M | Open |
How Many Employees Work at Elies Biotech?
Unlock and access historical data on people associated with Elies Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elies Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elies Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
